Persistent Tobacco Use After Treatment for Head, Neck Cancer

JAMA Otolaryngology–Head & Neck Surgery

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 12, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers access to the article This link will be live at the embargo time http://jama.jamanetwork.com/article.aspx?doi=10.1001/jamaoto.2022.0810

 

About The Study: Researchers found that a significant proportion of 89 patients with head and neck squamous cell carcinoma who were daily smokers at the time of diagnosis continued to smoke two years after treatment. Those who quit were most likely to do so in the first six months.

Authors: Samir S. Khariwala, M.D., M.S., of the University of Minnesota, Minneapolis, is the corresponding author.

 

(doi:10.1001/jamaoto.2022.0810)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.